AVXL
Price
$8.81
Change
-$0.05 (-0.56%)
Updated
Apr 14, 04:59 PM (EDT)
Capitalization
750.27M
24 days until earnings call
CRVO
Price
$9.71
Change
+$1.22 (+14.37%)
Updated
Apr 14, 04:59 PM (EDT)
Capitalization
84.24M
Ad is loading...

AVXL vs CRVO

Header iconAVXL vs CRVO Comparison
Open Charts AVXL vs CRVOBanner chart's image
Anavex Life Sciences
Price$8.81
Change-$0.05 (-0.56%)
Volume$9.41K
Capitalization750.27M
CervoMed
Price$9.71
Change+$1.22 (+14.37%)
Volume$6.51K
Capitalization84.24M
AVXL vs CRVO Comparison Chart
Loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVXL vs. CRVO commentary
Apr 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a Hold and CRVO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 15, 2025
Stock price -- (AVXL: $8.86 vs. CRVO: $8.49)
Brand notoriety: AVXL and CRVO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 61% vs. CRVO: 8%
Market capitalization -- AVXL: $750.27M vs. CRVO: $73.93M
AVXL [@Biotechnology] is valued at $750.27M. CRVO’s [@Biotechnology] market capitalization is $73.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $281.29B to $0. The average market capitalization across the [@Biotechnology] industry is $1.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 0 FA rating(s) are green whileCRVO’s FA Score has 0 green FA rating(s).

  • AVXL’s FA Score: 0 green, 5 red.
  • CRVO’s FA Score: 0 green, 5 red.
According to our system of comparison, CRVO is a better buy in the long-term than AVXL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 7 TA indicator(s) are bullish while CRVO’s TA Score has 4 bullish TA indicator(s).

  • AVXL’s TA Score: 7 bullish, 3 bearish.
  • CRVO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AVXL is a better buy in the short-term than CRVO.

Price Growth

AVXL (@Biotechnology) experienced а +8.18% price change this week, while CRVO (@Biotechnology) price change was -23.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.28%. For the same industry, the average monthly price growth was -13.99%, and the average quarterly price growth was -22.43%.

Reported Earning Dates

AVXL is expected to report earnings on Aug 12, 2025.

CRVO is expected to report earnings on Nov 13, 2023.

Industries' Descriptions

@Biotechnology (+4.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVXL($750M) has a higher market cap than CRVO($84.2M). CRVO YTD gains are higher at: 263.034 vs. AVXL (-17.505). CRVO has higher annual earnings (EBITDA): -7.83M vs. AVXL (-45.2M). AVXL has more cash in the bank: 121M vs. CRVO (46.7M). CRVO has less debt than AVXL: CRVO (0) vs AVXL (88.2K). AVXL (0) and CRVO (0) have equivalent revenues.
AVXLCRVOAVXL / CRVO
Capitalization750M84.2M891%
EBITDA-45.2M-7.83M578%
Gain YTD-17.505263.034-7%
P/E RatioN/A4.73-
Revenue00-
Total Cash121M46.7M259%
Total Debt88.2K0-
FUNDAMENTALS RATINGS
AVXL vs CRVO: Fundamental Ratings
AVXL
CRVO
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
48
Fair valued
PROFIT vs RISK RATING
1..100
73100
SMR RATING
1..100
9394
PRICE GROWTH RATING
1..100
3935
P/E GROWTH RATING
1..100
10054
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRVO's Valuation (48) in the Biotechnology industry is in the same range as AVXL (62). This means that CRVO’s stock grew similarly to AVXL’s over the last 12 months.

AVXL's Profit vs Risk Rating (73) in the Biotechnology industry is in the same range as CRVO (100). This means that AVXL’s stock grew similarly to CRVO’s over the last 12 months.

AVXL's SMR Rating (93) in the Biotechnology industry is in the same range as CRVO (94). This means that AVXL’s stock grew similarly to CRVO’s over the last 12 months.

CRVO's Price Growth Rating (35) in the Biotechnology industry is in the same range as AVXL (39). This means that CRVO’s stock grew similarly to AVXL’s over the last 12 months.

CRVO's P/E Growth Rating (54) in the Biotechnology industry is somewhat better than the same rating for AVXL (100). This means that CRVO’s stock grew somewhat faster than AVXL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVXLCRVO
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
85%
Momentum
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 26 days ago
81%
Bullish Trend 13 days ago
81%
Declines
ODDS (%)
Bearish Trend 11 days ago
80%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 5 days ago
84%
View a ticker or compare two or three
Ad is loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FGDAX34.601.88
+5.75%
Fidelity Advisor Gold A
EEMAX12.220.37
+3.12%
Columbia Emerging Markets A
FARMX17.160.50
+3.00%
Fidelity Agricultural Productivity
JMGMX44.970.69
+1.56%
JPMorgan Mid Cap Growth R6
ALOCX14.260.16
+1.13%
Alger Mid Cap Focus C

CRVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRVO has been loosely correlated with TCRX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CRVO jumps, then TCRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVO
1D Price
Change %
CRVO100%
+0.30%
TCRX - CRVO
34%
Loosely correlated
+9.73%
LVTX - CRVO
28%
Poorly correlated
+0.93%
VKTX - CRVO
27%
Poorly correlated
+3.25%
NKTR - CRVO
27%
Poorly correlated
+23.76%
AVXL - CRVO
27%
Poorly correlated
+3.75%
More